TY  - GEN
AU  - Moldovan,D
AU  - Reshef,A
AU  - Fabiani,J
AU  - Kivity,S
AU  - Toubi,E
AU  - Shlesinger,M
AU  - Triggiani,M
AU  - Montinaro,V
AU  - Cillari,E
AU  - Realdi,G
AU  - Cancian,M
AU  - Visscher,S
AU  - Zanichelli,A
AU  - Relan,A
AU  - Cicardi,M
TI  - Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study
SN  - 1365-2222
PY  - 2013///0108
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Angioedemas, Hereditary
KW  - drug therapy
KW  - Complement C1 Inhibitor Protein
KW  - administration & dosage
KW  - Complement Inactivating Agents
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Recombinant Proteins
KW  - therapeutic use
KW  - Risk Factors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2222.2012.03984.x
ER  -